Editorial dated yesterday in the Journal of the American Medical...

Editorial dated yesterday in the Journal of the American Medical Association: 'Strategic Opportunities to Improve Stroke Systems of Care'; an excerpt:

'To improve transport destination decision-making, better affordable tools are needed for on-scene LVO (large vessel occlusion) detection. Current EMS (emergency medical services) screening examination tools have important limitations and misclassify a substantial proportion of patients. In the RACECAT trial, about one-third of included patients did not have an LVO. New low-cost portable devices based on electroencephalography or near-infrared spectroscopy (my emphasis) hold future promise to improve LVO detection, but simulation modeling suggests that the optimal transport destination will still rely on geography, proximity of resources, traffic patterns, and local environmental factors'.

Interesting that there's no mention of microwave-based devices, so evidently still a low profile internationally, demonstrating that the share price doesn't yet include an element for widespread medical recognition and anticipation. When the device gets out there it's almost certainly going to be a disruptive event in the stroke care world (and hopefully a disruptive event for the share price, too - perhaps soonish via the imminent trials).